Skip to main content

Table 2 Disease-related characteristics in gout patients

From: Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study

  Gout (n = 226)  
Comorbiditiesb
 Hypertension 96 (42.5)  
 DM 23 (10.2)  
 Hyperlipidemia 25 (11.1)  
 Cardiovascular disease 22 (9.7)  
 Nephropathy 17 (7.5)  
 Disease duration (year)C 5 (2–12)  
 Number of flares/last yearC 3 (1.25–12)  
Stage of goutb
 Asymptomatic (hyperuricemia) 8 (3.5)  
 Acute phase 128 (56.6)  
 Intercritical phase 37 (16.4)  
 Chronic phase 53 (23.5)  
Number of tophib
 No 136 (60.2)  
 1 37 (16.4)  
  ≥ 2 53 (23.5)  
sUA (μmol/L)a 468.15 ± 116.59  
Presence of tender joints, yesb 190 (84.1)  
Presence of swollen joints, yesb 162 (71.7)  
Total pain (VAS)C 4.25(0–7.75)  
Urate lowering therapyb
 Allopurinol 16 (7.1)  
 Febuxostat 80 (35.4)  
Any anti-inflammatory drugsb
 Colchicine 146 (64.6)  
 NSAID 105 (46.5)  
 Corticosteroids 71 (31.4)  
  1. SD: standard deviation; IQR: interquartile range; DM: diabetes; NSAID: non-steroidal anti-inflammatory drugs
  2. aMean ± SDbNumber (percentage)CMedian (IQR)